ONYX PHARMACEUTICALS INC: cashflow_investing

Value{"amount": -282673000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2009-01-01 – 2009-09-30
Statuscurrent
EntityONYX PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950123-10-100148 · Open the official SEC filing →
Retrieved: 2026-08-19T09:49:46.140887+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001012140/cashflow-investing/2009-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/bf421ce9-1871-4eb2-9371-ec2e4e20be38

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies